Gastric Secretion

Gastric secretion is the integrated output of the stomach mucosa — acid, enzymes, mucus, bicarbonate, intrinsic factor and hormones — orchestrated to digest food while protecting the mucosa itself. For NEET PG, the parietal-cell proton pump, the three secretory phases and their regulation, and the pharmacology built on top of them (PPIs, H2 blockers, Zollinger-Ellison syndrome) are perennial favourites.

Functional anatomy of gastric glands

The stomach is divided functionally into the oxyntic (acid-secreting) mucosa of the fundus and body, and the pyloric gland mucosa of the antrum. Each region houses distinct cell types.

Cell type	Location	Secretion	Primary stimulus
Parietal (oxyntic) cell	Body/fundus	HCl + intrinsic factor	Gastrin, histamine, ACh
Chief (peptic) cell	Body/fundus	Pepsinogen, gastric lipase	ACh, secretin, acid
Mucous neck cell	Body/fundus	Soluble mucus	ACh
Surface mucous (foveolar) cell	All regions	Mucus + bicarbonate	Prostaglandins, irritation
G cell	Antrum	Gastrin	GRP, peptides, vagus
D cell	Antrum + body	Somatostatin	Low luminal pH (H⁺)
Enterochromaffin-like (ECL) cell	Body/fundus	Histamine	Gastrin, ACh

High-yield: Intrinsic factor is the ONLY indispensable gastric secretion — it is essential for vitamin B12 absorption in the terminal ileum. HCl, pepsin and gastrin are all dispensable for survival (achlorhydric patients live; B12-deficient patients develop pernicious anaemia/SACD).

Composition of gastric juice

Gastric juice (~2-2.5 L/day) is a mixture of two secretions: a parietal-cell secretion (pure isotonic HCl, ~160 mmol/L, pH ~0.8) and a non-parietal alkaline secretion (Na⁺-rich, like plasma). The relationship between secretion rate and electrolyte composition is classic:

• At high secretion rates → juice resembles pure parietal secretion → H⁺ high, Na⁺ low.
• At low (basal) rates → non-parietal component dominates → Na⁺ high, H⁺ low.
• K⁺ is always slightly higher than plasma (hence hypokalaemia with prolonged vomiting).
• Cl⁻ is the dominant anion throughout.

High-yield: Prolonged vomiting → loss of H⁺ and Cl⁻ → hypochloraemic, hypokalaemic metabolic alkalosis with paradoxical aciduria (kidneys exchange H⁺ for Na⁺ to conserve volume despite alkalosis).

The parietal cell and the proton pump

This is the single most tested concept. HCl generation hinges on the H⁺-K⁺-ATPase (the "proton pump") on the apical (canalicular) membrane.

Mechanism (stepwise):

1. Intracellular CO₂ + H₂O → (carbonic anhydrase) → H₂CO₃ → H⁺ + HCO₃⁻.
2. H⁺ is pumped into the canaliculus by H⁺-K⁺-ATPase in exchange for K⁺ (primary active transport, consumes ATP).
3. HCO₃⁻ leaves across the basolateral membrane in exchange for Cl⁻ (the "alkaline tide" — venous blood leaving the stomach after a meal is alkaline).
4. Cl⁻ then exits apically through a channel into the canaliculus; H⁺ + Cl⁻ → HCl.
5. K⁺ and Cl⁻ recycle to sustain the pump.

High-yield: The alkaline tide (post-prandial rise in blood/urine pH) is a direct consequence of basolateral HCO₃⁻ export. Heavy vomiting therefore produces metabolic alkalosis not only by H⁺ loss but by ongoing parietal-cell HCO₃⁻ generation that is no longer neutralised by reabsorbed luminal acid.

When the parietal cell is stimulated, tubulovesicles fuse with the apical membrane, massively expanding the secretory canaliculus and inserting more H⁺-K⁺-ATPase — a morphological switch from resting to active state.

The three receptors on the parietal cell

Agonist	Receptor	Source	Second messenger
Histamine	H2	ECL cells	↑ cAMP (Gs)
Acetylcholine	M3	Vagus / enteric neurons	↑ Ca²⁺, IP₃ (Gq)
Gastrin	CCK-B (CCK2)	Antral G cells	↑ Ca²⁺, IP₃ (Gq)

High-yield: Histamine is the dominant/final common pathway. Gastrin and ACh act largely by stimulating ECL cells to release histamine (paracrine amplification). This is why H2 blockers reduce acid evoked by all three stimuli, and why histamine potentiates gastrin/ACh effects.

Both ACh and gastrin also act on the somatostatin-secreting D cell — ACh inhibits D cells (removing the brake on acid), while luminal acid stimulates D cells (negative feedback).

Regulation: the three phases of secretion

Acid secretion is classically described in three overlapping phases. Cephalic → Gastric → Intestinal.

1. Cephalic phase (~30%) — Triggered by sight, smell, taste, thought, chewing of food. Mediated entirely by the vagus nerve. The vagus acts directly via M3 on parietal cells, and indirectly by releasing gastrin-releasing peptide (GRP/bombesin) onto G cells. This is the phase abolished by vagotomy and is the basis of "sham feeding" studies.

2. Gastric phase (~60%, the largest) — Triggered when food enters the stomach. Two stimuli:

• Distension → local + vagovagal reflexes → ACh.
• Chemical (peptides, amino acids, especially phenylalanine and tryptophan, plus caffeine, alcohol, calcium) → direct G-cell stimulation → gastrin. Gastrin then drives ECL histamine release. Falling luminal pH (<3) activates D cells → somatostatin → shuts off gastrin (autoregulation).

3. Intestinal phase (~10%) — Begins when chyme enters the duodenum. Has a brief stimulatory component (intestinal gastrin, absorbed amino acids) but is dominated by inhibition:

• Enterogastrones: secretin (released by acid), CCK, and especially GIP (gastric inhibitory peptide).
• The enterogastric reflex — duodenal acid, fat, hypertonicity and distension reflexively inhibit gastric secretion and motility.

High-yield: Largest phase = gastric (~60%). Phase abolished by vagotomy = cephalic. Net effect of the intestinal phase = inhibitory (protects duodenum from acid load).

Pepsinogen, pepsin and other enzymes

Chief cells secrete pepsinogen (inactive zymogen). Activation: luminal HCl (pH < 5, optimal ~2) cleaves pepsinogen to active pepsin, which then autocatalytically activates more pepsinogen. Pepsin is an endopeptidase optimally active at pH 1.8-3.5 and irreversibly inactivated at pH > 6 (hence inactive once chyme is neutralised in the duodenum). Gastric lipase contributes modestly to fat digestion (more important in neonates). Rennin (chymosin) curdles milk in infants.

The mucus-bicarbonate barrier (mucosal protection)

The stomach protects itself from autodigestion via the "gastric mucosal barrier":

1. Mucus gel layer — adherent, unstirred, traps bicarbonate.
2. Bicarbonate secretion by surface cells, neutralising H⁺ within the gel so the epithelial surface stays near pH 7 even when the lumen is pH 2 (a pH gradient across the mucus).
3. Hydrophobic phospholipid lining, tight junctions, and high mucosal blood flow (clears back-diffused H⁺).
4. Prostaglandins (PGE₂, PGI₂) are the master protectors — they ↑ mucus and bicarbonate, ↑ blood flow, and inhibit acid secretion.

High-yield: NSAIDs cause ulcers by inhibiting COX-1 → ↓ prostaglandins → loss of mucosal protection. Misoprostol (a PGE₁ analogue) is used to prevent NSAID-induced ulcers. This is the most-tested protective-barrier fact.

Clinical correlations

Zollinger-Ellison syndrome (ZES)

A gastrinoma (gastrin-secreting neuroendocrine tumour, usually in the "gastrinoma triangle" — junctions of cystic/CBD, 2nd/3rd duodenum, neck/body of pancreas). ~25% are part of MEN-1 (pancreas + parathyroid + pituitary).

• Features: severe, multiple, refractory or distal (post-bulbar/jejunal) peptic ulcers, diarrhoea (acid inactivates pancreatic lipase → steatorrhoea; large fluid volume), GERD.
• Best initial test: fasting serum gastrin (markedly elevated, often >1000 pg/mL). Stop PPIs before testing (PPIs raise gastrin).
• Confirmatory: secretin stimulation test — in ZES, secretin paradoxically raises gastrin (rise > 120 pg/mL); normal G cells are inhibited by secretin.
• Gastric pH < 2 with high gastrin (rules out other causes of hypergastrinaemia such as atrophic gastritis where pH is high).
• Management: high-dose PPI (drug of choice for acid control); localise and resect tumour.

Cause of ↑ gastrin	Gastric acid / pH
Zollinger-Ellison (gastrinoma)	High acid, low pH
Chronic atrophic gastritis / pernicious anaemia	Low acid, high pH (loss of D-cell feedback)
PPI therapy	Low acid, high pH (drug effect)

High-yield: Secretin inhibits normal gastrin but stimulates gastrinoma gastrin — the basis of the secretin stimulation (provocation) test. High gastrin + LOW pH = gastrinoma; high gastrin + HIGH pH = atrophic gastritis.

Pernicious anaemia / autoimmune gastritis

Autoimmune destruction of parietal cells (anti-parietal cell and anti-intrinsic factor antibodies) → loss of IF and HCl → vitamin B12 deficiency (megaloblastic anaemia, subacute combined degeneration), achlorhydria, and secondary hypergastrinaemia (no acid → no D-cell brake) predisposing to gastric carcinoid (ECL hyperplasia) and adenocarcinoma.

Pharmacology built on gastric physiology

• Proton pump inhibitors (omeprazole, pantoprazole) — irreversibly inhibit H⁺-K⁺-ATPase; prodrugs activated in the acidic canaliculus; most effective acid suppressors; best taken before meals (need active pumps). Long-term: hypomagnesaemia, ↓ B12/iron/Ca absorption, C. difficile risk, hypergastrinaemia.
• H2 receptor blockers (ranitidine, famotidine) — block histamine H2; useful but less potent; tolerance develops.
• Misoprostol — PGE₁ analogue, restores mucosal defence; contraindicated in pregnancy (abortifacient).
• Antimuscarinics (pirenzepine) — block M3/M1; largely historical.
• Sucralfate — forms protective coat over ulcer base in acid medium.

High-yield: PPIs irreversibly block the final common effector (the pump) regardless of stimulus, making them more effective than H2 blockers, which only block one of three pathways.

Approach: evaluating suspected acid hypersecretion

Recurrent/atypical peptic ulcer → check H. pylori & NSAID use first → if negative or ulcers multiple/refractory → fasting serum gastrin → if elevated, measure gastric pH → low pH → secretin stimulation test → positive → localise gastrinoma (somatostatin receptor scintigraphy / Ga-68 DOTATATE PET, EUS) → screen for MEN-1.

Key differentials

Feature	Peptic ulcer (common)	Zollinger-Ellison	Atrophic gastritis
Acid output	Normal/high	Very high	Low/absent
Serum gastrin	Normal	Very high	Very high
Ulcer pattern	Single, duodenal bulb	Multiple, distal	Usually none
Common cause	H. pylori, NSAIDs	Gastrinoma	Autoimmune
B12	Usually normal	Normal	Low

Recently asked / exam angle

• "Final common pathway / dominant mediator of acid secretion" → Histamine (H2 receptor → cAMP). Repeatedly tested.
• Phase of gastric secretion abolished by vagotomy → cephalic; largest phase → gastric.
• Mechanism of PPIs → irreversible inhibition of H⁺-K⁺-ATPase.
• Alkaline tide → due to basolateral HCO₃⁻/Cl⁻ exchange in parietal cells.
• Secretin stimulation test interpretation in ZES (paradoxical gastrin rise).
• Stimulus for D cell / somatostatin → low luminal pH (negative feedback on gastrin).
• Indispensable gastric secretion → intrinsic factor.
• Vomiting acid-base picture → hypochloraemic hypokalaemic metabolic alkalosis with paradoxical aciduria.
• NSAID ulcer mechanism / role of misoprostol → prostaglandin (COX-1) inhibition.
• Receptor-second messenger matching: H2→cAMP (Gs); M3 & CCK-B→IP₃/Ca²⁺ (Gq).
• Site of intrinsic factor & B12 absorption → IF from parietal cells; complex absorbed in terminal ileum.

Mnemonics

• "GAP" stimulators of parietal cell = Gastrin, Acetylcholine, Paracrine histamine. The inhibitors = somatostatin + prostaglandins + secretin/GIP (enterogastrones).
• Cells of the gland — "P-C-M-G-D-E": Parietal (HCl/IF), Chief (pepsinogen), Mucous neck (mucus), G (gastrin), D (somatostatin), ECL (histamine).
• ZES localisation = "Passaro's gastrinoma triangle."

Rapid revision

1. Parietal cells secrete HCl + intrinsic factor; chief cells secrete pepsinogen.
2. Acid generated by apical H⁺-K⁺-ATPase; basolateral HCO₃⁻/Cl⁻ exchange → alkaline tide.
3. Three parietal receptors: H2 (cAMP), M3 (Gq), CCK-B/gastrin (Gq); histamine is the dominant final pathway.
4. ECL cells release histamine in response to gastrin and ACh — the amplification step.
5. Phases: cephalic (vagal, ~30%) → gastric (largest, ~60%) → intestinal (net inhibitory, ~10%).
6. D-cell somatostatin is the master brake; triggered by low luminal pH (negative feedback).
7. Pepsinogen → pepsin needs **acid (pH <5)**; pepsin is inactivated at pH >6 in the duodenum.
8. Mucosal defence = mucus-bicarbonate barrier + prostaglandins + blood flow; NSAIDs break it.
9. Vagotomy abolishes the cephalic phase; intrinsic factor is the only indispensable secretion.
10. ZES: high gastrin + LOW gastric pH + paradoxical gastrin rise on secretin test; 25% with MEN-1; treat with high-dose PPI.
11. Atrophic gastritis/pernicious anaemia: high gastrin + HIGH pH + low B12 + anti-IF antibodies.
12. PPIs irreversibly inhibit the proton pump (final effector) → most potent acid suppression; take before meals.